Holen Sie sich die Stockscreener-App
19.57
0.41%
0.08
Handel nachbörslich:
19.57
Schlusskurs vom Vortag:
$19.49
Offen:
$19.67
24-Stunden-Volumen:
1.42M
Relative Volume:
0.96
Marktkapitalisierung:
$1.79B
Einnahmen:
$12.59M
Nettoeinkommen (Verlust:
$-212.39M
KGV:
-6.343
EPS:
-3.0853
Netto-Cashflow:
$-185.92M
1W Leistung:
-0.96%
1M Leistung:
+12.28%
6M Leistung:
+99.90%
1J Leistung:
+49.73%
1-Tages-Spanne:
$18.81
$19.82
1-Wochen-Bereich:
$18.81
$20.80
52-Wochen-Spanne:
$5.1501
$20.80
Immunome Inc Stock (IMNM) Company Profile
Firmenname
Immunome Inc
Sektor
Branche
Telefon
610-321-3700
Adresse
18702 N. CREEK PARKWAY, BOTHELL
Vergleichen Sie IMNM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IMNM
Immunome Inc
|
19.57 | 1.79B | 12.59M | -212.39M | -185.92M | -3.0853 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Immunome Inc Stock (IMNM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-01 | Eingeleitet | Truist | Buy |
| 2025-09-22 | Eingeleitet | Goldman | Buy |
| 2025-09-05 | Eingeleitet | Craig Hallum | Buy |
| 2025-04-02 | Eingeleitet | Lake Street | Buy |
| 2024-11-08 | Eingeleitet | Stephens | Overweight |
| 2024-05-31 | Eingeleitet | Piper Sandler | Overweight |
| 2024-04-30 | Eingeleitet | JP Morgan | Overweight |
| 2024-04-15 | Eingeleitet | Guggenheim | Buy |
| 2024-01-29 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-19 | Eingeleitet | Wedbush | Outperform |
| 2021-10-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Immunome Inc Aktie (IMNM) Neueste Nachrichten
Immunome, Inc. (NASDAQ:IMNM) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Immunome stock hits 52-week high at $20.50 - Investing.com
Immunome, Inc. (IMNM) -6.5% in After-hours: What’s Driving the Move? - Stocks Telegraph
Can Immunome Inc stock deliver strong Q4 earningsTrade Volume Report & Risk Managed Investment Signals - moha.gov.vn
What drives Immunome Inc stock priceEarnings Surprise Analysis & Make Confident Moves With Forecasting Models - earlytimes.in
Understanding Momentum Shifts in (IMNM) - news.stocktradersdaily.com
Is Immunome Inc (IMNM) positioned for future growth? - setenews.com
Kennedy Capital Management LLC Purchases 94,627 Shares of Immunome, Inc. $IMNM - MarketBeat
Immunome initiated with a Buy at Truist - MSN
Tema Etfs LLC Takes $1.07 Million Position in Immunome, Inc. $IMNM - MarketBeat
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Immunome (NASDAQ:IMNM) Stock Price Up 9.5%Time to Buy? - MarketBeat
Is Immunome Inc a good long term investmentSwing Trading Ideas & Superior Capital Appreciation - earlytimes.in
Immunome (NASDAQ:IMNM) Hits New 1-Year HighShould You Buy? - MarketBeat
Immunome (NASDAQ:IMNM) Trading Down 6.7%Here's Why - MarketBeat
Immunome stock hits 52-week high at 19.16 USD By Investing.com - Investing.com Australia
Immunome stock hits 52-week high at 19.16 USD - Investing.com
It makes sense and dollars to buy Immunome Inc (IMNM) stock - setenews.com
Truist Financial Initiates Coverage on Immunome (NASDAQ:IMNM) - MarketBeat
Immunome (NASDAQ:IMNM) Coverage Initiated by Analysts at Truist Financial - Defense World
Immunome (IMNM) Stock Analysis Report | Financials & Insights - Benzinga
Truist Securities initiates coverage on Immunome stock with Buy rating By Investing.com - Investing.com South Africa
IMNM: Truist Securities Initiates Coverage with 'Buy' Rating and - GuruFocus
Truist Securities initiates coverage on Immunome stock with Buy rating - Investing.com India
Truist Initiates Immunome at Buy With $36 Price Target - marketscreener.com
Intech Investment Management LLC Buys 6,141 Shares of Immunome, Inc. $IMNM - Defense World
Geode Capital Management LLC Has $17.31 Million Stock Holdings in Immunome, Inc. $IMNM - MarketBeat
Avoiding Lag: Real-Time Signals in (IMNM) Movement - news.stocktradersdaily.com
How institutional buying supports Immunome Inc. stock2025 Trading Recap & Real-Time Stock Entry Alerts - moha.gov.vn
Immunome Inc Stock Analysis and ForecastSell Signals and Alerts & Free Proven Portfolio Growth Strategies - earlytimes.in
Immunome to Present at Upcoming December 2025 Investor Conferences - BioSpace
Immunome (NASDAQ:IMNM) Sets New 12-Month HighHere's Why - MarketBeat
Immunome Inc (IMNM) is looking forward to a strong quarter - Setenews
Immunome to Present at Upcoming Investor Conferences - marketscreener.com
Immunome price target raised to $33 from $25 at Stephens - MSN
Immunome (NASDAQ:IMNM) Upgraded at Wall Street Zen - Defense World
Immunome, Inc. $IMNM Shares Sold by Primecap Management Co. CA - MarketBeat
Immunome, Inc.Common Stock (NQ: IMNM - Markets Financial Content
Immunome stock hits 52-week high at $18.79 By Investing.com - Investing.com Nigeria
Immunome stock hits 52-week high at $18.79 - Investing.com
Will Immunome Inc. stock attract more institutional investorsEarnings Overview Summary & Fast Momentum Stock Entry Tips - newser.com
What technical signals suggest for Immunome Inc. stockEarnings Overview Summary & AI Driven Stock Movement Reports - newser.com
How Immunome Inc. stock benefits from tech adoptionTrade Analysis Summary & Short-Term Trading Alerts - newser.com
Will Immunome Inc. stock outperform value stocks2025 Geopolitical Influence & Weekly Top Performers Watchlists - newser.com
Is Immunome Inc. stock a safe haven assetGDP Growth & Weekly Top Gainers Trade List - newser.com
Is Immunome Inc. stock bottoming out2025 Bull vs Bear & Risk Controlled Stock Pick Alerts - newser.com
Immunome (NASDAQ:IMNM) Stock Price Expected to Rise, Stephens Analyst Says - Defense World
Can swing trading help recover from Immunome Inc. lossesJuly 2025 Action & Daily Volume Surge Signals - newser.com
Lake Street Sticks to Their Buy Rating for Immunome (IMNM) - The Globe and Mail
Immunome announces $125 million stock offering - MSN
Finanzdaten der Immunome Inc-Aktie (IMNM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.08%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):